68 results
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
8 May 24
Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
or death. Your healthcare provider should do blood tests and physical exams before starting and during treatment to check your liver function. Tell … your healthcare provider right away if you get any signs or symptoms of liver problems, including nausea or vomiting, skin or the white part of the eye
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
28 Feb 24
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
4:05pm
and can worsen during treatment with LIVMARLI. These changes may be a sign of liver injury and can be serious. Your healthcare provider should do blood … tests before starting and during treatment to check your liver function. Tell your healthcare provider right away if you get any signs or symptoms
8-K
wilzpppw4ekfj
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
8-K
EX-99.1
jb6jeeb
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
8-K
EX-99.1
2rw79td45xdt4bs8e9ev
2 Nov 23
Results of Operations and Financial Condition
4:06pm
S-3ASR
y545y97yuju
13 Oct 23
Automatic shelf registration
4:47pm
8-K
EX-99.1
07we6cw
13 Oct 23
Other Events
4:16pm
8-K
0k0wkefsncya1edwu
11 Sep 23
Departure of Directors or Certain Officers
4:16pm
8-K
EX-99.1
emeetmjj
5 Sep 23
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
8:36am
8-K
fy2d i28l6q
30 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.1
197nxeyx 4u4c5n0p
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-2.1
y1ft95
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
poakem ii
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-99.1
q58fdfa
4 May 23
Results of Operations and Financial Condition
4:02pm